{"nct_id":"NCT01621802","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2012-06-21","start_date_type":"ACTUAL","primary_completion_date":"2015-07-06","primary_completion_date_type":"ACTUAL","completion_date":"2015-11-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}